Off the Scales — the impact of weight-loss jabs, from our bodies to the pharma sector
一场关于食欲、身体与商业的化学革命

Focusing on Novo Nordisk, Aimee Donnellan’s book ranges across R&D, patents, medical effects and the stigma attached to obesity
GLP-1药物不仅是医学突破，更演变为一场深刻的社会变革。它瓦解了关于肥胖与意志力的传统叙事，重塑制药业竞争格局，并开始冲击食品、时尚等行业，迫使人们重新思考身体、健康与消费的关系。